NEU 5.64% $21.34 neuren pharmaceuticals limited

Continuous disclosure requirements are clear in s.674 of...

  1. 864 Posts.
    lightbulb Created with Sketch. 1613
    Continuous disclosure requirements are clear in s.674 of Corporations Act 2001 (Cth). Companies do not have the discretion to time announcements for particular days of the week.

    Why would there be a trading halt prior to the announcement @Tangentland @gingerclam?
    There was no TH prior to the announcement of Trofinetide Ph2 headline results, Ph3 results or FDA approval. I don't see any reason for a TH for NNZ-2591 Ph2 headline results, but perhaps you have a compelling argument.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$21.34
Change
1.140(5.64%)
Mkt cap ! $2.725B
Open High Low Value Volume
$20.30 $21.65 $20.11 $14.34M 673.1K

Buyers (Bids)

No. Vol. Price($)
2 633 $21.30
 

Sellers (Offers)

Price($) Vol. No.
$21.34 2000 2
View Market Depth
Last trade - 16.10pm 15/05/2024 (20 minute delay) ?
Last
$21.37
  Change
1.140 ( 5.63 %)
Open High Low Volume
$20.26 $21.64 $20.19 136487
Last updated 15.59pm 15/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.